98 related articles for article (PubMed ID: 23155263)
1. Medullomyoblastoma: a case report and literature review of a rare tumor entity.
Smolle E; Al-Qubati S; Stefanits H; Haberler C; Kleinert R; Haybaeck J
Anticancer Res; 2012 Nov; 32(11):4939-44. PubMed ID: 23155263
[TBL] [Abstract][Full Text] [Related]
2. [A case of medullomyoblastoma].
Aramaki Y; Shimokawa S; Nakashima S; Nakamura Y
No Shinkei Geka; 2011 Nov; 39(11):1073-7. PubMed ID: 22036819
[TBL] [Abstract][Full Text] [Related]
3. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
4. Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.
Helton KJ; Fouladi M; Boop FA; Perry A; Dalton J; Kun L; Fuller C
Cancer; 2004 Sep; 101(6):1445-54. PubMed ID: 15368333
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin.
Kido M; Ueno M; Onodera M; Matsumoto K; Imai T; Haba R; Tamiya T; Huang CL; Sakamoto H
Pathol Int; 2009 Apr; 59(4):255-60. PubMed ID: 19351370
[TBL] [Abstract][Full Text] [Related]
6. Medullomyoblastoma: teratoid nature of a quite rare neoplasm.
Er U; Yigitkanli K; Kazanci B; Ozturk E; Sorar M; Bavbek M
Surg Neurol; 2008 Apr; 69(4):403-6. PubMed ID: 18261773
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
[TBL] [Abstract][Full Text] [Related]
8. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
9. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
Inda MM; Muñoz J; Coullin P; Fauvet D; Danglot G; Tuñón T; Bernheim A; Castresana JS
Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784
[TBL] [Abstract][Full Text] [Related]
10. Medullomyoblastoma with calcification: a case report.
Chaturvedi S; Gupta S; Singhal S; Kumari R
Neuropathology; 2008 Feb; 28(1):93-7. PubMed ID: 18181837
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
[TBL] [Abstract][Full Text] [Related]
12. Cerebellar medullomyoblastoma with melanotic tubular structures.
Nozza P; Milanaccio C; Piatelli G; Rossi A; Raso A; Cama A; Garré ML; Pietsch T
Pediatr Blood Cancer; 2008 Jan; 50(1):183-5. PubMed ID: 16550533
[TBL] [Abstract][Full Text] [Related]
13. Development of medullomyoblastoma from classical medulloblastoma following a long term latency.
Yokoo H; Maeshima A; Sasaki A; Hirato J; Nakazato Y; Tamura M
Noshuyo Byori; 1995; 12(2):91-6. PubMed ID: 8867688
[TBL] [Abstract][Full Text] [Related]
14. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
[TBL] [Abstract][Full Text] [Related]
15. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
16. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
19. WNT-activated medulloblastoma with melanotic and myogenic differentiation: Report of a rare case.
Rajeshwari M; Kakkar A; Nalwa A; Suri V; Sarkar C; Satyarthee GD; Garg A; Sharma MC
Neuropathology; 2016 Aug; 36(4):372-5. PubMed ID: 26869281
[TBL] [Abstract][Full Text] [Related]
20. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
